Prevalence and genotypes of α- and β-thalassemia carriers in Hong Kong - Implications for population screening

New England Journal of Medicine

Volumn 336, Issue 18, 1997, Pages 1298-1301

  Lau, Yu Lung ^a   Chan, Li Chong ^a   Chan, Yuk Yin A ^a   Ha, Shau Yin ^a   Yeung, Chap Yung ^a   Waye, John S ^b   Chui, David H K ^b,c  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b MCMASTER UNIVERSITY   (Canada)

^c MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ALPHA THALASSEMIA; ARTICLE; BETA THALASSEMIA; CHROMOSOME 16; FERRITIN BLOOD LEVEL; GENE DELETION; GENETIC COUNSELING; GENETIC SCREENING; GENOTYPE; GLOBIN GENE; HETEROZYGOTE; HONG KONG; HUMAN; MAJOR CLINICAL STUDY; PRENATAL DIAGNOSIS; PREVALENCE; PRIORITY JOURNAL;

ADOLESCENT; ALPHA-THALASSEMIA; BETA-THALASSEMIA; FEMALE; GENOTYPE; HETEROZYGOTE; HONG KONG; HUMANS; MALE; MASS SCREENING; MUTATION; PREGNANCY; PRENATAL DIAGNOSIS; PREVALENCE;

EID: 0030905118     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199705013361805     Document Type: Article

References (28)

1. Weatherall DJ. The thalassemias. In: Beutler E, Lichtman MA, Coller BS, Kipps TJ, eds. Williams hematology. 5th ed. New York: McGraw-Hill, 1995:581-615.
2. Fucharoen S, Winichagoon P. Hemoglobinopathies in Southeast Asia. Hemoglobin 1987;11:65-88. [Erratum, Hemoglobin 1988;12:99.]
3. Chan LC, So JCC, Chui DHK. Comparison of haemoglobin H inclusion bodies with embryonic ζ globin in screening for α thalassaemia. J Clin Pathol 1995;48:861-4.
4. -SEA/) deletional α-thalassacmia. Lancet 1993; 342:1145-7.
5. Wave JS, Eng B, Cai SP, et al. Carrier detection and prenatal diagnosis of hemoglobinopathies in Ontario. Clin Invest Med 1993;16:358-71.
6. Chan AYY, So CKC, Chan LC. Comparison of the HbH inclusion test and a PCR test in routine screening for α thalassaemia in Hong Kong. J Clin Pathol 1996;49:411-3.
7. 0 thalassemia deletion: comparison to other deletions in the human β-globin gene cluster and sequence analysis of the breakpoints. Nucleic Acids Res 1985; 13:6559-75.
8. Chan V, Chan TK, Chebab FF, Todd D. Distribution of β-thalassemia mutations in south China and their association with haplotypes. Am J Hum Genet 1987;41:678-85.
9. Zhang JZ, Cai SP, He X, et al. Molecular basis of beta thalassemia in south China: strategy for DNA analysis. Hum Genet 1988;78:37-40.
10. Liang R, Liang S, Jiang NH, et al, α and β Thalassaemia among Chinese children in Guangxi Province, PR. China: molecular and haematological characterization. Br J Haematol 1994;86:351-4.
11. Mitchell JJ, Capua A, Clow C, Scriver CR. Twenty-year outcome analysis of genetic screening programs for Tay-Sachs and β-thalassernia disease carriers in high schools. Am J Hum Genet 1996;59:793-8.
12. Todd D, Lai MCS, Braga CA, Soo HN. Alpha-thalassaemia in Chinese: cord blood studies. Br J Haematol 1969;16:551-6.
13. Li AMC, Lee FT, Todd D. The screening of Chinese cord blood for haemoglobinopathies. Hum Hered 1982;32:62-70.
14. Ghosh A, Woo JSK, Wan CW, et al. Evaluation of a prenatal screening procedure for β-thalassaemia carriers in a Chinese population based on the mean corpuscular volume (MCV). Prenat Diagn 1985;5:59-65.
15. Gardner MJ, Gardner SB, Winter PD. Confidence interval analysis (CIA): microcomputer program manual, version 1-1. London: British Medical Journal, 1991.
16. Higgs DR, Vickers MA, Wilkie AOM, Pretorius I-M, Jarman AP, Weatherall DJ. A review of the molecular genetics of the human α-globin gene cluster. Blood 1989;73:1081-104.
17. Chan V, Chan TK, Cheng MY, Kan YW, Todd D. Organization of the ζ-α genes in Chinese. Br J Haematol 1986;64:97-105.
18. Higgs DR. α-Thalassaemia. Baillieres Clin Haematol 1993;6:117-50.
19. Yuen HL. Cooley's anaemia, present situation in Hong Kong: 15th anniversary special issue. Hong Kong; Cooley's Anaemia Association, 1996:31-3.
20. Kwan EYW, Lee ACW, Li AMC, et al. A cross-sectional study of growth, puberty and endocrine function in patients with thalassaemia major in Hong Kong. J Paediatr Child Health 1995;31:83-7.
21. Prenatal diagnosis and genetic screening: community and service implications: summary and recommendations of a report of the Royal College of Physicians. J R Coll Physicians Lond 1989;23:215-20.
22. Brittenham GM, Griffith PM, Nienhuis AW, et al. Efficacy of deferoxamine in preventing complications of iron overload in patients with thalassemia major. N EngI J Med 1994;331:567-73.
23. Olivieri NF, Nathan DG, MacMillan JH, et al. Survival in medically treated patients with homozygous β-thalassemia. N Engl J Med 1994;331: 574-8.
24. Dover GJ, Valle D. Therapy for β-thalassemia - a paradigm for the treatment of genetic disorders. N Engl J Med 1994;331:609-10.
25. Lee ACW, Lau YL, Chan CF, et al. Bone marrow transplantation for thalassemia in Hong Kong: the early experience. Bone Marrow Transplant 1993;12:Suppl 1:49-50.
26. Nathan DG. Genes, blood, and courage: a boy called Immortal Sword. Cambridge, Mass.: Harvard University Press, 1995:193.
27. Cao A. 1993 William Allan award address. Am J Hum Genet 1994;54: 397-402.
28. Modell B, Kuliev AM. A scientific basis for cost-benefit analysis of genetics services. Trends Genet 1993;9:46-52.